PharmaCare

Drug Review Results

Drug Review Process

Before being considered for inclusion as benefits under the PharmaCare program, all drugs must be reviewed.

For information on the drug review process in Canada and in British Columbia, please refer to our information sheet.

Drug Review Results Information

Available Now - This page provides information on:

• all drugs reviewed by the national Common Drug Review (CDR) and subsequently submitted to PharmaCare for consideration;
• all drug reviews completed by PharmaCare on or after January 1, 2005; and
• basic information on the brand name drugs currently under review by PharmaCare and the CDR.

Information on the review of generic drugs is not included as these reviews are usually completed within 6 to 8 weeks of receipt of a manufacturer's submission.

Coming Soon - We are assembling supplemental information on the progress of each drug through the PharmaCare review process. This information, which will include the rationale for decisions on whether or not to list a drug, will be posted as it becomes available.

For information on the benefit status of drugs not included below, please contact our HelpDesk